GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Net-Net Working Capital

HALB (Halberd) Net-Net Working Capital : $0.00 (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Halberd's Net-Net Working Capital for the quarter that ended in Jul. 2023 was $0.00.

The industry rank for Halberd's Net-Net Working Capital or its related term are showing as below:

HALB's Price-to-Net-Net-Working-Capital is not ranked *
in the Biotechnology industry.
Industry Median: 4.12
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Halberd Net-Net Working Capital Historical Data

The historical data trend for Halberd's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Net-Net Working Capital Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Net-Net Working Capital
-0.02 - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Net-Net Working Capital -0.02 - -

Competitive Comparison of Halberd's Net-Net Working Capital

For the Biotechnology subindustry, Halberd's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd's Price-to-Net-Net-Working-Capital Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Halberd's Price-to-Net-Net-Working-Capital falls into.


;
;

Halberd Net-Net Working Capital Calculation

Halberd's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Jul. 2023 is calculated as

Net-Net Working Capital(A: Jul. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.007+0.75 * 0+0.5 * 0-0.939
-0.001-0)/565.875
=-0.00

Halberd's Net-Net Working Capital (NNWC) per share for the quarter that ended in Jul. 2023 is calculated as

Net-Net Working Capital(Q: Jul. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.007+0.75 * 0+0.5 * 0-0.939
-0.001-0)/565.875
=-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Halberd  (OTCPK:HALB) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Halberd Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Halberd's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236